Last $1.90 USD
Change Today +0.07 / 3.83%
Volume 852.8K
As of 8:10 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas J. Garrity

Independent Director, Chairman of Audit Committee and Member of Governance & Nominating Committee, Antares Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 1 different industries.

See Board Relationships
65$171,880

Background*

Mr. Thomas J. Garrity served as Executive Vice President and Chief Financial Officer for PCS Health Systems, from 1994 to 2000. Mr. Garrity played a key role during its subsequent integration with Advance Paradigm, Inc. and became Executive Vice President, Financial Operations for the resultant entity, AdvancePCS. Mr. Garrity held various positions at Eli Lilly and Company, including Director of Public Policy and Planning and Development, Director Corporate, Financial ...

Read Full Background

Corporate Headquarters*

100 Princeton South
Ewing, New Jersey 08628

United States

Phone: 609-359-3020
Fax: --

Board Members Memberships*

2003-Present
Independent Director, Chairman of Audit Committee and Member of Governance & Nominating Committee

Education*

MBA
The University of Chicago
BS
Massachusetts Institute of Technology

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$61,879
Total Calculated Compensation$171,880
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATRS:US $1.90 USD +0.07

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William M. Greenman Chief Executive Officer, President and Director
Cerus Corporation
$495.8K
Howard Zauberman Chief Executive Officer, President and Director
Vision-Sciences Inc.
$210.9K
Gary R. Maharaj Chief Executive Officer, President and Director
SurModics, Inc.
$435.0K
Robert C.E. Kill Chairman, Chief Executive Officer and President
Uroplasty, Inc.
$589.2K
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
$503.7K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTARES PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.